Skip to main content
Top navigation
  • Sustainability reports
  • Focus area: Increase resource efficiency
  • Governance
  • Please fill out this field

Main navigation

    • Our offering
        • Solids & others
            • Manufacturing
                • Solids
                • Semi-solids
                • Liquids
                • Pharmaceutical packaging
                • Controlled drugs
                • High Potent
        • Sterile delivery
            • Manufacturing
                • Sterile vial filling
                • PFS and cartridges
                • Lyophilisation
                • Blow-fill-seal
                • Ampoules
            • Specialised services
                • Ophthalmics
                • Beta-lactams
                • Vaccine manufacturing
        • Advanced Bio
            • Modalities & services
                • xRNA therapies
                • Virus & viral vectros
                • Microbial & live biotherapeutic products
                • Recombinant proteins
            • Continuous manufacturing
            • Innovations & collaborations
        • Additional services
            • ReciPredict
            • Analytical services
            • Regulatory
            • Parenteral drug development
            • New product introduction
                • Technology Transfer
                • Product development
    • Resources
    • About us
        • About us
            • Our leadership
            • Why partner with us
            • Locations
        • Sustainability
            • Sustainability reports
            • Sustainability strategy
            • Net Zero commitment
            • Governance
        • News & Events
            • Press releases
            • Events
    • Careers
        • Careers
            • Who we are
            • Working with us
            • What you can do
            • Job search
    • Contact
Linkedin
Contact
Please fill out this field
No banner Image

Press releases

  • Home
  • About us
  • Press releases
  • Facebook
  • Linkedin
  • Twitter
  • Email

BU-NOT-SET

CONTACT US
January 10 2022
Recipharm announces sale of Fontaine-lès-Dijon site to Astrea
September 24 2021
First customer boards Recipharm's soft mist inhaler technology platform
August 24 2021
Recipharm launches new laboratory to expand analytical services offering
July 15 2021
Recipharm invests in fill finish capacity
July 06 2021
Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco
March 09 2021
Recipharm publishes Annual Report 2020
March 02 2021
Recipharm names 2020 International Environmental Award winner
February 10 2021
Recipharm bolsters biologics offering
February 01 2021
Recipharm and Medspray launch Resyca® joint venture to exploit novel softmist technology for pharmaceutical applications
January 28 2021
Recipharm AB publishes report for the fourth quarter and full year 2020

Pagination

  • First page
  • Previous page
  • …
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Next page
  • Last page

Footer Webfrom

contact form

Let’s discuss your 
next project

Share your details and start your journey with our global CDMO team.

Stay updated
https://se.linkedin.com/company/recipharm https://www.youtube.com/channel/UCr-bw7pCCkYZfeImOwTfNRg
Footer
  • Privacy policy
  • Cookies
  • Website terms
  • Sitemap
  • Cookie settings
  • Terms & conditions
  • Code of Conduct
© 2026

Recipharm AB. All rights reserved. RECIPHARM® is a registered trademark owned by Recipharm AB.

Delivered by Investisdigital [iDX]